| Stage | HCA | % of rev | DIS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $19.8B | 100.00% | $25.2B | 100.00% | DIS ×1.27 |
| Gross profit | $11.3B | 56.77% | $10.1B | 40.17% | HCA +16.6pp |
| Operating income | $3.0B | 14.90% | $4.8B | 18.85% | DIS +4.0pp |
| Pre-tax income | $2.4B | 11.94% | $3.6B | 14.44% | DIS +2.5pp |
| Net income | $1.8B | 9.32% | $2.8B | 11.26% | DIS +1.9pp |
| Stage | HCA | DIS | Gap · A − B |
|---|---|---|---|
| Revenue | $19.8B100.00% | $25.2B100.00% | DIS ×1.27 |
| Gross profit | 56.77%$11.3B | 40.17%$10.1B | HCA +16.6pp |
| Operating income | 14.90%$3.0B | 18.85%$4.8B | DIS +4.0pp |
| Pre-tax income | 11.94%$2.4B | 14.44%$3.6B | DIS +2.5pp |
| Net income |
| 9.32%$1.8B |
| 11.26%$2.8B |
| DIS +1.9pp |
No shared counterparties.